157 related articles for article (PubMed ID: 28496132)
1. Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.
Noman AS; Uddin M; Chowdhury AA; Nayeem MJ; Raihan Z; Rashid MI; Azad AK; Rahman ML; Barua D; Sultana A; Shirin A; Ferdous J; Parag RR; Rahman SM; Mahmud MR; Jerin CS; Jahan N; Siddiqua A; Ara T; Sabur EB; Alam SS; Baidya S; Akther S; Rahman MZ; Banu T; Murugan AK; Sabri S; Islam SMS; Karakas B; Aboussekhra A; Yeger H; Farhat WA; Islam SS
Sci Rep; 2017 May; 7(1):1796. PubMed ID: 28496132
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh.
Noman AS; Uddin M; Rahman MZ; Nayeem MJ; Alam SS; Khatun Z; Wahiduzzaman M; Sultana A; Rahman ML; Ali MY; Barua D; Ahmed I; Islam MS; Aboussekhra A; Yeger H; Farhat WA; Islam SS
Sci Rep; 2016 Jan; 6():18830. PubMed ID: 26727947
[TBL] [Abstract][Full Text] [Related]
3. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients.
Ahmed OI; Adel AM; Diab DR; Gobran NS
Egypt J Immunol; 2006; 13(2):61-8. PubMed ID: 18689272
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
Zhang GJ; Adachi I
Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
[TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.
Salgado R; Junius S; Benoy I; Van Dam P; Vermeulen P; Van Marck E; Huget P; Dirix LY
Int J Cancer; 2003 Feb; 103(5):642-6. PubMed ID: 12494472
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.
Ravishankaran P; Karunanithi R
World J Surg Oncol; 2011 Feb; 9():18. PubMed ID: 21294915
[TBL] [Abstract][Full Text] [Related]
9. Serum IL-6 and IL-12 levels in breast cancer patients.
Hussein MZ; Al Fikky A; Abdel Bar I; Attia O
Egypt J Immunol; 2004; 11(2):165-70. PubMed ID: 16734129
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 as a prognostic marker for breast cancer: a meta-analysis.
Lin S; Gan Z; Han K; Yao Y; Min D
Tumori; 2015; 101(5):535-41. PubMed ID: 26045123
[TBL] [Abstract][Full Text] [Related]
11. Importance of serum IL-18 and RANTES as markers for breast carcinoma progression.
Eissa SA; Zaki SA; El-Maghraby SM; Kadry DY
J Egypt Natl Canc Inst; 2005 Mar; 17(1):51-5. PubMed ID: 16353083
[TBL] [Abstract][Full Text] [Related]
12. High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab.
Hara M; Nagasaki T; Shiga K; Takahashi H; Takeyama H
Surg Today; 2017 Apr; 47(4):483-489. PubMed ID: 27549777
[TBL] [Abstract][Full Text] [Related]
13. High expression of Sonic hedgehog signaling proteins is related to the favorable outcome, EGFR mutation, and lepidic predominant subtype in primary lung adenocarcinoma.
Kim JE; Kim H; Choe JY; Sun P; Jheon S; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S570-6. PubMed ID: 23709101
[TBL] [Abstract][Full Text] [Related]
14. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
Tas F; Oguz H; Argon A; Duranyildiz D; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(3):241-6. PubMed ID: 16110135
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional Profiling of Sonic Hedgehog in a Prospective Cohort of Breast Cancer in a Pakistani Population.
Riaz SK; Ye L; Sahar NE; Aman D; Qadir J; Khan JS; Saeed M; Jiang WG; Malik MFA
Anticancer Res; 2017 Aug; 37(8):4449-4454. PubMed ID: 28739739
[TBL] [Abstract][Full Text] [Related]
16. Is sonic Hedgehog involved in human fracture healing? --a prospective study on local and systemic concentrations of SHH.
Eipeldauer S; Thomas A; Hoechtl-Lee L; Kecht M; Binder H; Koettstorfer J; Gregori M; Sarahrudi K
PLoS One; 2014; 9(12):e114668. PubMed ID: 25501422
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome.
Tripsianis G; Papadopoulou E; Anagnostopoulos K; Botaitis S; Katotomichelakis M; Romanidis K; Kontomanolis E; Tentes I; Kortsaris A
Neoplasma; 2014; 61(2):205-12. PubMed ID: 24299316
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
[TBL] [Abstract][Full Text] [Related]
19. Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer.
Peng C; Wallwiener M; Rudolph A; Ćuk K; Eilber U; Celik M; Modugno C; Trumpp A; Heil J; Marmé F; Madhavan D; Nees J; Riethdorf S; Schott S; Sohn C; Pantel K; Schneeweiss A; Chang-Claude J; Yang R; Burwinkel B
Int J Cancer; 2016 May; 138(10):2499-509. PubMed ID: 26686298
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.
Banys-Paluchowski M; Fehm T; Janni W; Aktas B; Fasching PA; Kasimir-Bauer S; Milde-Langosch K; Pantel K; Rack B; Riethdorf S; Solomayer EF; Witzel I; Müller V
BMC Cancer; 2018 May; 18(1):541. PubMed ID: 29739347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
